Article
Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.